E Seront

Publishing 2025

Is this you? Claim this profile
1
Article
160
Reads on Journament
24
Co-authors
1
Journal

This page collects the articles indexed under the name E Seront. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 1

  1. A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM).
    R Galot, C Le Tourneau, L Licitra, J Guigay, A Kong, I Tinhofer, C Even, A Daste, S Henry, C Borel, C Abdeddaim, E Seront and 13 more
    esmo open 2025 160 reads

Possible papers by E Seront 1

Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.

  1. Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects
    as Emmanuel Seront The Journal of clinical investigation 2015
    Same name only

Under these spellings

Same person? Claim this profile, then add these papers one by one or combine a whole spelling.

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

Also published as

Tick the other spellings that are you. Leave the rest.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Frequent co-authors

Publishes in